Endometriosis Management Guidelines

First-Line Medical Management

• The American College of Obstetricians and Gynecologists recommends NSAIDs as the initial approach for endometriosis-related pain, followed by hormonal therapies including combined oral contraceptives, progestins, or GnRH agonists for at least three months when NSAIDs are insufficient 1, 2
• Combined oral contraceptives are effective for pain relief with similar efficacy to other hormonal treatments 1

Second-Line Medical Management

• GnRH agonists must be used for at least 3 months to provide significant pain relief and add-back therapy is mandatory for long-term use to reduce bone mineral loss without compromising pain relief efficacy 1, 2, 3
• Danazol appears equally effective as GnRH agonists when used for at least 6 months 3

Surgical Considerations

• For severe endometriosis, medical treatment alone may not be sufficient, and surgical exploration is warranted if conservative treatments fail 1, 3
• Up to 44% of women experience symptom recurrence within one year after surgery 1

Special Populations

• HRT with estrogen is not contraindicated following hysterectomy and bilateral salpingo-oophorectomy for endometriosis 1, 3
• For women with endometriosis who required oophorectomy, combined estrogen/progestogen therapy can treat vasomotor symptoms and may reduce risk of disease reactivation 4
• Postmenopausal women with endometriomas are at higher risk of malignant transformation and require vigilant monitoring 3

Complementary Approaches

• Heat application to abdomen or back may reduce cramping pain 2
• Acupressure on specific points may help reduce pain 2
• Aromatherapy with lavender may increase satisfaction and reduce pain or anxiety 2

Critical Pitfalls to Avoid

• No medical therapy completely eradicates endometriosis lesions—treatment is suppressive, not curative 2
• Long-term GnRH agonist use without add-back therapy causes significant bone mineral loss 1, 2, 3
• Progestins are not supported for adjuvant treatment after surgical staging of endometrial cancer (distinct from endometriosis) 5, 6